Prawo i regulacje · 26/08/2019

AMRI Renesselaer, Inc. Files Application to Become Bulk Manufacturer of Controlled Substances

AMRI Renesselaer, Inc. has submitted a request to the U.S. Drug Enforcement Administration (DEA) to become a bulk manufacturer of controlled substances, a significant step towards expanding its pharmaceutical production capabilities.